Wendy A. Cooper

11.3k total citations · 3 hit papers
131 papers, 5.7k citations indexed

About

Wendy A. Cooper is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Wendy A. Cooper has authored 131 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 58 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Wendy A. Cooper's work include Lung Cancer Treatments and Mutations (53 papers), Cancer Genomics and Diagnostics (28 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Wendy A. Cooper is often cited by papers focused on Lung Cancer Treatments and Mutations (53 papers), Cancer Genomics and Diagnostics (28 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Wendy A. Cooper collaborates with scholars based in Australia, United States and United Kingdom. Wendy A. Cooper's co-authors include Sandra O’Toole, Michael Boyer, Maija R.J. Kohonen‐Corish, Steven Kao, Brian C. McCaughan, Christina Selinger, Richard A. Scolyer, Annabelle Mahar, Lisa G. Horvath and David Lam and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer and Oncogene.

In The Last Decade

Wendy A. Cooper

128 papers receiving 5.6k citations

Hit Papers

The 2021 WHO Classificati... 2017 2026 2020 2023 2021 2017 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
    2021 752 citations Andrew G. Nicholson, Ming‐Sound Tsao et al. Journal of Thoracic Oncology profile →
  2. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
    2017 539 citations Nick Pavlakis, Michael Boyer et al. profile →
  3. Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma
    2017 405 citations Chee Khoon Lee, Sarah J. Lord et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wendy A. Cooper 2.9k 2.5k 2.0k 1.4k 561 131 5.7k
Lisa G. Horvath 2.5k 0.9× 2.2k 0.9× 2.4k 1.2× 1.6k 1.2× 449 0.8× 198 6.0k
Marius Ilié 2.3k 0.8× 3.3k 1.3× 1.8k 0.9× 2.4k 1.8× 615 1.1× 165 5.9k
Caicun Zhou 3.4k 1.2× 3.6k 1.4× 1.6k 0.8× 957 0.7× 734 1.3× 209 5.6k
Åslaug Helland 2.3k 0.8× 2.7k 1.1× 2.7k 1.4× 1.8k 1.3× 784 1.4× 190 6.0k
Kyung-Hun Lee 2.0k 0.7× 4.1k 1.6× 1.6k 0.8× 1.5k 1.1× 346 0.6× 216 6.0k
Daniele Generali 1.7k 0.6× 3.1k 1.2× 2.5k 1.3× 2.1k 1.5× 475 0.8× 232 6.2k
David S. Shames 2.4k 0.8× 2.9k 1.1× 3.0k 1.5× 1.9k 1.4× 522 0.9× 110 6.1k
Julia A. Beaver 1.5k 0.5× 2.7k 1.1× 1.1k 0.6× 1.1k 0.8× 519 0.9× 131 4.8k
Edwin M. Posadas 1.9k 0.6× 1.9k 0.8× 2.7k 1.4× 1.9k 1.4× 442 0.8× 173 5.6k
Young Kwang Chae 1.9k 0.6× 3.1k 1.2× 2.6k 1.3× 1.7k 1.3× 820 1.5× 274 6.4k

Countries citing papers authored by Wendy A. Cooper

Since Specialization
Citations

This map shows the geographic impact of Wendy A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy A. Cooper more than expected).

Fields of papers citing papers by Wendy A. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy A. Cooper. The network helps show where Wendy A. Cooper may publish in the future.

Co-authorship network of co-authors of Wendy A. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy A. Cooper. A scholar is included among the top collaborators of Wendy A. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy A. Cooper. Wendy A. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations
3.
Cooper, Wendy A., Stephen Wade, Kwun M. Fong, et al.. (2025). Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis. Scientific Reports. 15(1). 4166–4166. 5 indexed citations
4.
Cooper, Wendy A., Fleur Webster, Kelly J. Butnor, et al.. (2024). Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 86(5). 665–680.
5.
Barnes, Hayley, Tamera J. Corte, Gregory J. Keir, et al.. (2024). Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 29(12). 1023–1046. 1 indexed citations
6.
Harrison, Megan, Helen E. Jo, Lauren Troy, et al.. (2024). Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. Respiratory Medicine. 224. 107533–107533. 1 indexed citations
7.
Kerr, Keith M., Lukas Bubendorf, Fernando López‐Ríos, et al.. (2023). Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. Histopathology. 84(3). 429–439. 8 indexed citations
8.
Klebe, Sonja, Meagan Judge, Luka Brčić, et al.. (2023). Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 84(4). 633–645. 4 indexed citations
9.
10.
Satgunaseelan, Laveniya, Dario Strbenac, Cali E. Willet, et al.. (2022). Whole genome duplication in oral squamous cell carcinoma in patients younger than 50 years: implications for prognosis and adverse clinicopathological factors. Genes Chromosomes and Cancer. 61(9). 561–571. 5 indexed citations
11.
Woodford, Rachel, Sarah J. Lord, Ian C. Marschner, et al.. (2022). PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer. Future Oncology. 18(14). 1793–1799. 8 indexed citations
12.
13.
Satgunaseelan, Laveniya, Andrew J. Colebatch, Annabelle Mahar, et al.. (2021). ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1. Pathology. 54(4). 399–403. 6 indexed citations
14.
Nicholson, Andrew G., Ming‐Sound Tsao, Mary Beth Beasley, et al.. (2021). The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. Journal of Thoracic Oncology. 17(3). 362–387. 752 indexed citations breakdown →
15.
Cooper, Wendy A., Annabelle Mahar, Jeffrey L. Myers, et al.. (2020). Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features. Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 203(10). 1306–1313. 30 indexed citations
16.
Li, Ziduo, Edward Abadir, Candice Clarke, et al.. (2020). Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody. Clinical & Translational Immunology. 9(7). e1156–e1156. 3 indexed citations
17.
Troy, Lauren, Christopher Grainge, Tamera J. Corte, et al.. (2019). Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study. BMJ Open Respiratory Research. 6(1). e000443–e000443. 13 indexed citations
18.
Blinman, Prunella, et al.. (2018). Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes. BioEssays. 40(8). e1800050–e1800050. 7 indexed citations
19.
Cooper, Wendy A., Prudence A. Russell, Edwina Duhig, et al.. (2017). Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(16). 4569–4577. 100 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa G. Horvath Breakdown of academic impact, for papers by Marius Ilié Breakdown of academic impact, for papers by Caicun Zhou Breakdown of academic impact, for papers by Åslaug Helland Breakdown of academic impact, for papers by Kyung-Hun Lee Breakdown of academic impact, for papers by Daniele Generali Breakdown of academic impact, for papers by David S. Shames Breakdown of academic impact, for papers by Julia A. Beaver Breakdown of academic impact, for papers by Edwin M. Posadas Breakdown of academic impact, for papers by Young Kwang Chae
Rankless by CCL
2026